Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Beta-Blocker Heart Attack Trial in perspective.

S Goldstein

    Cardiology
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Beta-blockers like propranolol significantly reduced mortality and coronary events in heart attack survivors. These drugs were well-tolerated and decreased arrhythmias, supporting their routine use post-myocardial infarction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure.

    Journal of the American College of Cardiology·1992
    Same author

    Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to haemodynamics and sympathoadrenergic activation.

    European heart journal·1992
    Same author

    Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure.

    Journal of molecular and cellular cardiology·1992
    Same author

    Activation of the coagulation system in women with mitral stenosis and sinus rhythm.

    The American journal of cardiology·1992
    Same author

    Telomere length predicts replicative capacity of human fibroblasts.

    Proceedings of the National Academy of Sciences of the United States of America·1992
    Same author

    Effects of vasodilator therapy on survival in patients with chronic heart failure.

    Progress in cardiovascular diseases·1992
    Same journal

    Aortic Valve Sclerosis: More Than an Incidental Echocardiographic Finding.

    Cardiology·2026
    Same journal

    Can resting segmental strain identify obstructive coronary artery disease in chronic coronary syndrome patients referred to CABG?

    Cardiology·2026
    Same journal

    Mortality Impact of Stroke and Major Bleeding Across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure With Prevalent Atrial Fibrillation.

    Cardiology·2026
    Same journal

    Impact of Inflammatory Disorders on Outcomes in Acute Heart Failure: A Nationwide Analysis.

    Cardiology·2026
    Same journal

    Predictors and Clinical Impact of Tricuspid Regurgitation After Pericardiectomy for Constrictive Pericarditis.

    Cardiology·2026
    Same journal

    Utilization of Guideline-Directed Medical Therapies and Transcatheter-Edge-to-Edge Repair in Patients with Significant Secondary Mitral Regurgitation.

    Cardiology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Acute myocardial infarction (MI) poses significant mortality risks.
    • Post-MI management aims to reduce mortality, morbidity, and prevent re-infarction.

    Purpose of the Study:

    • To evaluate the efficacy and safety of propranolol in patients following acute myocardial infarction.
    • To assess the impact of propranolol on mortality, coronary events, and ventricular arrhythmias.

    Main Methods:

    • The Beta-Blocker Heart Attack Trial involved administering propranolol to patients post-MI.
    • A placebo group was used for comparison.
    • Follow-up averaged 25 months.

    Main Results:

    • Propranolol treatment resulted in a 26% decrease in total mortality.

    Related Experiment Videos

  • A 23% reduction in total coronary events was observed in the propranolol group.
  • The drug was well-tolerated, with a decreased incidence of ventricular arrhythmias.

    • Conclusions:

    • Routine administration of beta-adrenergic blocking agents, including propranolol, is beneficial for post-myocardial infarction patients.
    • Beta-blockers improve outcomes by reducing mortality, coronary events, and arrhythmias.